Form 4 for ANIP ANI PHARMACEUTICALS INC

Accepted 2023-07-21 00:00:00 ET · period of report 2023-07-19 · accession 0001104659-23-083131 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2023-07-21	2023-07-19+	ANIP	Shanmugam Muthusamy	HEAD OF R, D, COO-NOVITIUM OPS, Dir	S - Sale	$52.02	-23.5K	1.23M	-2%	-$1.22M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-07-19	S	D	5,969	$51.48	1,250,120	I Held by Esjay LLC	—	—	(F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.95 to $52.28, inclusive. The reporting person undertakes to provide to ANI Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4 and 5 to this Form 4. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
2	Common	Common Stock	2023-07-20	S	D	6,000	$51.52	1,244,120	I Held by Esjay LLC	—	—	(F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.00 to $52.08, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
3	Common	Common Stock	2023-07-21	S	D	11,500	$52.56	1,232,620	I Held by Esjay LLC	—	—	(F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.10 to $53.32, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.